Skip to Main Content

Paper Details

Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2).
J Allergy Clin Immunol Pract
24
2021
Author NameAffiliation
Jonathan A BernsteinUniversity of Cincinnati
Timothy J CraigPenn State University
William R Lumry
Bruce L ZurawUniversity of California San Diego
  • 1 - 4

Datasets

Release 1.2